Valuation: GKB Ophthalmics Limited

Market Cap 323M 3.36M 2.98M 2.78M 2.54M 4.78M 4.83M 33.68M 13.05M 165M 12.6M 12.33M 529M P/E 2025
-4.32x
P/E 2026 21.7x
Enterprise Value 395M 4.11M 3.65M 3.41M 3.11M 5.86M 5.91M 41.23M 15.98M 202M 15.43M 15.09M 648M EV / Sales 2025
0.29x
EV / Sales 2026 0.23x
Free-Float
21.95%
Yield 2025 *
-
Yield 2026 -
08-12 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
15/08/25 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/11/24 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/08/24 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/05/24 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/03/24 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/02/24 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/11/23 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
1 day-0.11%
1 week-3.16%
1 month+1.52%
3 months+1.41%
6 months+16.26%
Current year+24.90%
1 week 64
Extreme 64
66.3
1 month 61.61
Extreme 61.61
75.52
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
76.9
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 10/12/1981
Director of Finance/CFO - 01/04/2019
Chief Administrative Officer 62 01/06/2024
Director TitleAgeSince
Chairman 84 10/12/1981
Director/Board Member 58 24/07/1996
Director/Board Member 68 20/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%-3.16%-8.11%-36.79% 3.36M
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -0.24%-1.56%-10.67%+8.64% 69.02B
Weighted average by Cap. +0.03%-1.30%-17.07%+11.23%

Financials

2025 2026
Net sales 1.09B 11.34M 10.07M 9.4M 8.57M 16.16M 16.31M 114M 44.09M 557M 42.57M 41.64M 1.79B 1.49B 15.51M 13.78M 12.86M 11.72M 22.1M 22.31M 156M 60.3M 762M 58.22M 56.95M 2.45B
Net income -70.45M -733K -651K -608K -554K -1.04M -1.05M -7.35M -2.85M -36.01M -2.75M -2.69M -116M 12.18M 127K 113K 105K 95.81K 181K 182K 1.27M 493K 6.23M 476K 466K 19.99M
Net Debt 15.59M 162K 144K 134K 123K 231K 233K 1.63M 631K 7.97M 609K 596K 25.58M 72.38M 753K 669K 624K 569K 1.07M 1.08M 7.56M 2.93M 37M 2.83M 2.77M 119M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
156
Date Price Change Volume
30/09/26 ₹64.00 -0.11% 2,200
29/09/26 ₹64.07 -1.43% 1,577
28/09/26 ₹65.00 -1.65% 1,300